HK1169336A1 - Materials and methods relating to glycosylation of a therapeutic polypeptide - Google Patents
Materials and methods relating to glycosylation of a therapeutic polypeptideInfo
- Publication number
- HK1169336A1 HK1169336A1 HK12110238.7A HK12110238A HK1169336A1 HK 1169336 A1 HK1169336 A1 HK 1169336A1 HK 12110238 A HK12110238 A HK 12110238A HK 1169336 A1 HK1169336 A1 HK 1169336A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- glycosylation
- materials
- therapeutic polypeptide
- methods relating
- relating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18743409P | 2009-06-16 | 2009-06-16 | |
PCT/GB2010/001188 WO2010146362A2 (en) | 2009-06-16 | 2010-06-16 | Materials and methods relating to glycosylation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1169336A1 true HK1169336A1 (en) | 2013-02-22 |
Family
ID=43086298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12110238.7A HK1169336A1 (en) | 2009-06-16 | 2012-10-17 | Materials and methods relating to glycosylation of a therapeutic polypeptide |
Country Status (9)
Country | Link |
---|---|
US (1) | US9452223B2 (xx) |
EP (1) | EP2442831B9 (xx) |
JP (2) | JP6091892B2 (xx) |
CN (1) | CN102481377B (xx) |
CA (1) | CA2768155C (xx) |
ES (1) | ES2560557T3 (xx) |
HK (1) | HK1169336A1 (xx) |
PL (1) | PL2442831T3 (xx) |
WO (1) | WO2010146362A2 (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010146362A2 (en) * | 2009-06-16 | 2010-12-23 | The University Of Bath | Materials and methods relating to glycosylation |
TW201442721A (zh) * | 2013-01-23 | 2014-11-16 | Daiichi Sankyo Co Ltd | 糖鏈修飾心房利尿鈉肽 |
CN106415244B (zh) * | 2014-03-27 | 2020-04-24 | 中央研究院 | 反应性标记化合物及其用途 |
RU2656140C2 (ru) * | 2016-11-14 | 2018-05-31 | Федеральное государственное бюджетное учреждение "Государственный научный центр Институт иммунологии" Федерального медико-биологического агентства России | Способ получения гибридного белка, состоящего из рекомбинантного белка аналога интерферона гамма, конъюгированного с олигосахаридом |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69231127D1 (de) * | 1991-03-18 | 2000-07-06 | Scripps Research Inst La Jolla | Oligosaccharide als enzymsubstrate und -inhibitoren: verfahren und zusammensetzungen |
US5770407A (en) * | 1996-12-10 | 1998-06-23 | The Scripps Research Institute | Process for preparing nucleotide inhibitors of glycosyltransferases |
EP2292271A3 (en) | 2001-10-10 | 2011-09-14 | BioGeneriX AG | Remodelling and glycoconjugation of an antibody |
US7226903B2 (en) | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta |
WO2004035605A2 (en) * | 2002-10-16 | 2004-04-29 | The Scripps Research Institute | Glycoprotein synthesis |
BRPI0809670A8 (pt) | 2007-04-03 | 2018-12-18 | Biogenerix Ag | métodos para aumentar a produção de célula tronco, para aumentar o número de granulócitos em um indivíduo, para prevenir, tratar e aliviar a mielossupressão que resulta de uma terapia contra o câncer, para tratar uma condição em um indivíduo, para tratar neutropenia e trombocitopenia em um mamífero, para expandir células tronco hematopoiéticas em cultura, para aumentar a hematopoiese em um indivíduo, para aumentar o número de célulars progenitoras hematopoiéticas em um indivíduo, e para fornecer enxerto estável da medula óssea, e, forma de dosagem oral. |
AU2008323768A1 (en) | 2007-11-09 | 2009-05-14 | Baxter Healthcare S.A. | Modified recombinant Factor VIII and von Willebrand Factor and methods of use |
WO2010146362A2 (en) * | 2009-06-16 | 2010-12-23 | The University Of Bath | Materials and methods relating to glycosylation |
-
2010
- 2010-06-16 WO PCT/GB2010/001188 patent/WO2010146362A2/en active Application Filing
- 2010-06-16 CA CA2768155A patent/CA2768155C/en active Active
- 2010-06-16 JP JP2012515554A patent/JP6091892B2/ja active Active
- 2010-06-16 PL PL10727485T patent/PL2442831T3/pl unknown
- 2010-06-16 CN CN201080031987.3A patent/CN102481377B/zh active Active
- 2010-06-16 EP EP10727485.4A patent/EP2442831B9/en active Active
- 2010-06-16 US US13/378,192 patent/US9452223B2/en active Active
- 2010-06-16 ES ES10727485.4T patent/ES2560557T3/es active Active
-
2012
- 2012-10-17 HK HK12110238.7A patent/HK1169336A1/xx unknown
-
2015
- 2015-06-16 JP JP2015121185A patent/JP2015187153A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2012530119A (ja) | 2012-11-29 |
EP2442831B9 (en) | 2016-05-11 |
WO2010146362A3 (en) | 2011-06-30 |
US9452223B2 (en) | 2016-09-27 |
PL2442831T3 (pl) | 2016-06-30 |
US20120190631A1 (en) | 2012-07-26 |
CN102481377B (zh) | 2014-10-29 |
EP2442831A2 (en) | 2012-04-25 |
CA2768155A1 (en) | 2010-12-23 |
JP6091892B2 (ja) | 2017-03-08 |
WO2010146362A2 (en) | 2010-12-23 |
EP2442831B1 (en) | 2015-11-04 |
JP2015187153A (ja) | 2015-10-29 |
CA2768155C (en) | 2016-08-23 |
CN102481377A (zh) | 2012-05-30 |
ES2560557T3 (es) | 2016-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201107702B (en) | Composition and methods related to protein a(spa)variants | |
ZA201209561B (en) | Compositions and methods related to protein a (spa) variants | |
IL252490A0 (en) | Ceramic-ceramic bonding and related methods | |
ZA201200122B (en) | Glucose-regulating polypeptides and methods of making and using same | |
IL215480A0 (en) | Control of protein glycosylation and compositions and methods relating thereto | |
EP2547771A4 (en) | PRODUCTION OF PROTEINS AND POLYPEPTIDES | |
HK1173654A1 (zh) | 治療化合物及相關的使用方法 | |
EP2440241A4 (en) | GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING THEM | |
IL216619A0 (en) | Recombinant production of peptides | |
EP2495255A4 (en) | GLYCOSYLATED FORM OF AN ANTIGENIC GLP-1 ANALOG | |
EP2655651A4 (en) | A cost-effective method for expressing and purifying recombinant proteins in plants | |
IL215537A (en) | Human recombinant alpha1-antitrapazine and a method for its production | |
IL216543A (en) | Methods for enhancing production of human recombinant wild strain of beta-glucosidase | |
HK1169336A1 (en) | Materials and methods relating to glycosylation of a therapeutic polypeptide | |
IL222714A0 (en) | Preparation of polypeptides and salts thereof | |
ZA201209021B (en) | Therapeutic peptide composition and method | |
HU0900706D0 (en) | Preparation and application of hobby- creative auxiliary material | |
PL2411890T3 (pl) | Interfejs dla systemu czujników planarnych i sposób sterowania nim | |
TWM365750U (en) | Adhesive structure of breathable plaster | |
GB0906676D0 (en) | Improvements in and relating to the consideration of evidence | |
GB0906275D0 (en) | Improvements in and relating to the consideration of evidence |